发明名称 EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED MOLECULES FOR TREATMENT OF INFLAMMATORY ARTHRITIS
摘要 The invention features a method for treating a patient having inflammatory arthritis, the method includes administering to the patient a molecule which is capable of specifically binding to an epidermal growth factor receptor expressed on a cell of the patient which contributes to the inflammatory arthritis of the patient, the molecule being capable of decreasing the viability of the cell.
申请公布号 AU2261392(A) 申请公布日期 1993.02.11
申请号 AU19920022613 申请日期 1992.06.16
申请人 SERAGEN, INC. 发明人 PATRICIA A BACHA
分类号 A61K38/00;A61K38/22;A61K39/395;A61K47/48;A61P29/00;A61P37/00;A61P43/00;C07K14/34;C07K14/485;C07K16/28;C12P21/08 主分类号 A61K38/00
代理机构 代理人
主权项
地址